Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-02-24 @ 12:49 PM
Study NCT ID:
NCT02569320
Status:
COMPLETED
Last Update Posted:
2021-06-15
First Post:
2015-10-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma
Sponsor:
Ohio State University Comprehensive Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
OSU-15004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |